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Domain of Fibronectin Is Consistent with a Non-linear
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Fibronectin-binding proteins (FnBPs) of Staphylococcus
aureus and Streptococcus pyogenes mediate invasion of human
endothelial and epithelial cells in a process likely to aid the per-
sistence and/or dissemination of infection. In addition to bind-
ing sites for the N-terminal domain (NTD) of fibronectin (Fn), a
number of streptococcal FnBPs also contain an upstream region
(UR) that is closely associated with an NTD-binding region; UR
binds to the adjacent gelatin-binding domain (GBD) of Fn. Pre-
viously, UR was shown to be required for efficient streptococcal
invasion of epithelial cells. Here we show, using a Streptococcus
zooepidemicus FnBP, that the UR-binding site in GBD resides
largely in the 8F19F1module pair.We also show thatUR inhibits
binding of a peptide from the 1 chain of type I collagen to
8F19F1 and that UR binding to 8F1 is likely to occur through
anti-parallel -zipper formation. Thus, we propose that strep-
tococcal proteins that contain adjacentNTD- andGBD-binding
sites form a highly unusual extended tandem -zipper that
spans the two domains andmediates high affinity binding to Fn
through a large intermolecular interface. The proximity of the
UR- andNTD-binding sequences in streptococcal FnBPs is con-
sistent with a non-linear arrangement ofmodules in the tertiary
structure of the GBD of Fn.
Many cell surface-anchored bacterial proteins bind extracel-
lular matrix proteins in the host. These proteins, also known as
MSCRAMMs (microbial surface components recognizing
adhesive matrix molecules) (1, 2), are likely to play roles in the
establishment, dissemination, and/or persistence of infection
by mediating interactions with host tissues. Fibronectin (Fn)7-
binding proteins (FnBPs) from Staphylococcus aureus (FnBPA/
FnBPB) (3) and Streptococcus pyogenes (SfbI/F1) (4) mediate
adhesion to and invasion of host cells (5–9), including endothe-
lial and epithelial cells. Fn is a large glycoprotein of 230 kDa
(monomer molecular mass) which is present in human plasma
in a soluble, dimeric form and in the extracellular matrix in an
insoluble form. Fn has amodular structure, composed of type 1,
type 2, and type 3 (F1, F2, and F3) modules that combine to
form functional domains (10, 11). The N-terminal domain
(NTD) is composed of five F1modules (1–5F1), and the adjacent
gelatin-binding domain (GBD) contains 6F11F22F27-8-9F1 (Fig.
1A). FnBPs from S. pyogenes, S. aureus, Streptococcus dysgalac-
tiae, and Borrelia burgdorferi bind to the NTD through a tan-
dem -zipper (12–15). In other words, within these FnBPs,
intrinsically disorderedNTD-binding bacterial repeats (FnBRs)
contain short motifs that form an anti-parallel -strand along the
triple-stranded -sheet of consecutive F1 modules in the NTD.
Structural evidence for this unusual mechanism of protein-pro-
tein recognition has been provided by both NMR spectroscopy
and x-ray crystallography for all five F1 modules of the NTD and
for several bacterial peptides (12, 14).AlthoughFnBPs fromstaph-
ylococci andstreptococci containmultipleFnBRs (2),BBK32 from
B. burgdorferi appears to contain only one (15).
As is clear from its name, the GBD has long been known to
bind gelatin (denatured collagen) (16). Recently, evidence for a
-zipper interaction between an F1 module of the GBD and a
synthetic peptide from the 1 chain of type I collagen was
obtained using both NMR spectroscopy and x-ray crystallogra-
phy. A crystal structure of a GBD module pair, 8F19F1, with
peptide bound (17) revealed that the collagen peptide forms an
anti-parallel -strand along the C-terminal (E) strand of triple-
stranded -sheet of 8F1. The GBD of Fn has also been shown
to be important for binding of pathogenic bacteria to Fn.
Talay et al. (18) showed that SfbI from S. pyogenes binds to
both NTD and GBD. Binding to GBD is mediated through a
spacer domain (also known as an upstream region (UR)) on
SfbI adjacent to and upstream of the FnBR region. Cell inva-
sion assays demonstrated that the SfbI UR and FnBR regions
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are both required for efficient invasion of streptococci into
the eukaryotic cell (18).
It is likely that bacterial peptides, in binding Fn, harness (and
probably modify) its normal physiological activity. Thus,
understanding the mechanism of interaction of FnBPs with Fn
will lead to a better understanding not only of the role of FnBPs
in infection but also of the activities of Fn itself and how they
might be controlled. For example, an S. pyogenes UR-contain-
ing peptide has been shown to reduce Fnmatrix polymerization
(19) and to increase turnover of Fn (20) and collagen I (21),
suggesting possible applications in reducing pathological
matrix remodeling (22).
Streptococcus zooepidemicus (Streptococcus equi subspecies
zooepidemicus) is a frequent cause of opportunistic pyogenic
infections in horses and also, although rarely, can cause human
infections (23). An FnBP from S. zooepidemicus, FnZ (Fig. 1B),
has a sequence organization similar to SfbI from S. pyogenes (2,
24), but the UR-like sequence lies between the first and second
of five putative FnBRs (2, 24) (Fig. 1B). The SfbI UR motif
LAGESGET is conserved in the FnZ UR (Fig. 1C) (24). Because
a similar motif is also present in the 1(I) collagen peptide (Fig.
1C), we hypothesized that bacterial peptides might bind to the
GBD via the same mechanism as collagen and compete with
collagen for Fn binding.
The aim of this work is to determine themechanism of bind-
ing of streptococcal FnBPs to the GBD. First, we show that a
S. zooepidemicus FnZpeptide binds both 8F19F1 andGBD. Sec-
ond, data are presented that support an anti-parallel -zipper
mode of binding for FnZ to 8F19F1. Last, we show that the
S. zooepidemicus FnZ peptide inhibits binding of the collagen
peptide to 8F19F1, presumably due to overlap of the binding
sites on 8F19F1. The role of conserved residues in 8F1-binding
motifs and the consequences of the proximity of the NTD- and
GBD-binding sites in the streptococcal proteins for the struc-
ture of Fn are also discussed.
EXPERIMENTAL PROCEDURES
Expression and Purification of Recombinant 8F19F1—Unla-
beled and uniformly 15N-labeled 8F19F1 module pair (Fn pre-
cursor residues 516–608) was expressed in Pichia pastoris
using a procedure similar to that described previously (25).
Secreted proteinwas concentrated from fermentationmedia by
cation exchange chromatography on a 5-ml SP-Sepharose Fast
Flow column (GEHealthcare) at pH 3.0, eluting with a gradient
from0 to 1MNaCl in 20mMcitric acid over 50 columnvolumes.
Fractions containing protein were incubated with Endo Hf
(New England Biolabs) at pH 5.5 to trim the sugars attached to
glycosylation sites at Asn528 and Asn542 back to a single
GlcNAc. 8F19F1 was further purified by gelatin affinity chro-
matography on an XK16 column (GE Healthcare) packed
with 20 ml of gelatin-Sepharose 4B (GE Healthcare). Protein
was loaded in phosphate-buffered saline (PBS) at pH 7.3 at
4 °C and eluted with a gradient from 0 to 4 M urea. The
protein was finally purified by size exclusion chromatogra-
phy on a HiLoad Superdex 75 gel filtration column (GE
Healthcare) equilibrated in 40 mM NaH2PO4/K2HPO4, pH
7.3, 150 mM NaCl. The 8F19F1 concentration was deter-
mined from absorbance at 280 nm, and the molecular weight
was confirmed by electrospray ionizationmass spectrometry
(ESI-MS). SDS-PAGE analysis of the purified protein
showed a single band.
Expression and Purification of FnZ—DNA for residues
370–428 of FnZ from S. zooepidemicus (24) was produced
synthetically (Entelechon) and cloned into a pGEX-6P-1
vector (GE Healthcare). The protein was expressed recom-
binantly in E. coli BL21 (DE3) as a GST-tagged fusion protein
using autoinduction. The fusion was isolated from soluble
bacterial cell lysates using a 5-ml GSTrap high performance
column (GE Healthcare) equilibrated in PBS, pH 7.3, and
eluted using 20 mM Tris-HCl, 50 mM NaCl, 10 mM reduced
glutathione, pH 7.0. Appropriate fractions were pooled, and
the glutathione was removed using dialysis. After cleavage of
the affinity tag using 3C protease (Novagen) (leaving five
vector residues, GPLGS, at the N terminus), the FnZ con-
struct was further purified using reversed phase high per-
formance liquid chromatography on a C4 Jupiter column
(Phenomenex). Buffer A was 0.15% trifluoroacectic acid
(TFA), and buffer B was 100% acetonitrile, 0.1% TFA. Protein
was loaded onto the column equilibrated in 10% buffer B and
eluted on a continuous linear gradient of 10–45% buffer B in
50 ml, and appropriate fractions were lyophilized. Concen-
tration measurements were made based on mass, and the
molecular weight was confirmed by ESI-MS.
Preparation of Fn Fragments and Synthetic Peptides—The
GBD of Fn was obtained as a lyophilized proteolytic fragment
(Sigma) and dialyzed into 10 mM NaH2PO4/K2HPO4 (pH 7.3)
before use. A recombinant Fn 100-kDa N-terminal fragment
(Fig. 1A) was expressed and purified as described else-
where (26) and dialyzed against PBS (pH 7.3) prior to use.
The S. zooepidemicus FnZ synthetic peptides (sequences
RNPHLMGIGGGLAGESGETTPK and LAGESGET) were
obtained from Alta Bioscience UK. The N and C termini of
the shorter peptide were capped by acetylation and amida-
tion, respectively; the termini of the longer peptide were
uncapped. Peptide concentration measurements were made
based on mass.
Isothermal Titration Calorimetry (ITC)—ITC experi-
ments were carried out using a VP-ITC microcalorimeter
(MicroCal Inc., Northampton, MA). In a typical experiment,
the cell contained 1.4 ml of Fn fragment (8F19F1, GBD, or
100 kDa), and the syringe contained 277 l of FnZ (synthetic
peptide or recombinant protein) at a concentration 10–20
times higher than that of the protein in the cell. If possible,
the cell concentration was chosen to correspond to a c value
of 100–1000, where c  [protein]/predicted Kd (27). Titra-
tions with 8F19F1 and GBD were carried out in 10 mM
NaH2PO4/K2HPO4, pH 7.4, at 25 °C. Both the cell and
syringe solutions were degassed at 20 °C for 15 min before
use. Both sets of titrations were carried out as follows. One
preinjection of 2 l of syringe solution was followed by 39
injections of 7 l at an injection speed of 0.5 l/s. Stirring
speed was 307 rpm, and there was a delay of 360 s between
injections. For both titrations, a separate heat of dilution
experiment was performed by injecting peptide into buffer.
The averaged heats of dilution were subtracted from the
main experiments. The titration with the 100-kDa Fn frag-
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ment was performed at 37 °C in PBS (pH 7.3) after degassing
both cell and syringe solutions at 30 °C for 15 min. One pre-
injection of 2 l of syringe solution was followed by 26 injec-
tions of 5 l at an injection speed of 0.5 l/s. Stirring speed
was 302 rpm, and there was a delay of 300 s between injec-
tions. The heat of dilution was taken as the average heat of
six points at the end of the titration. Data were analyzed
using MicroCal Origin software (version 7), with data being
fitted to a one-site binding model.
NMR Spectroscopy—All experiments were carried out at
25 °C on a Bruker Avance 700-MHz spectrometer. Samples
were prepared by dissolving uniformly labeled 15N-8F19F1 to a
concentration of 0.2 and 1.0 mM, for binding studies and con-
firmation of previous 8F19F1 assignments (25), respectively, in
90% H2O, 10% D2O containing 150 mMNaCl, 20 mM KH2PO4/
Na2HPO4, 0.02% sodium azide with pH adjusted to 7.2. A series
of heteronuclear single-quantum coherence (HSQC) experi-
ments with excitation sculpting for solvent suppression and
with sensitivity enhancement (28) were carried out with
increasing concentrations of synthetic FnZ and LAGESGET
peptides (0.05, 0.1, 0.15, 0.2, 1.0, 1.5, and 2.0mol eq) for binding
studies; three-dimensional 1H15N-HSQC-NOESY and 1H15N-
HSQC-TOCSY experiments were employed for spectral
assignment. HSQC peaks for most 8F19F1 residues were
assigned de novo in both free and FnZ peptide-bound spectra,
but for five peaks thatwere veryweak in the spectra of the 8F19F1-
peptide complex, assignments were based on assignments of the
8F19F1-collagen peptide complex
(17) (BMRB entry 15986). Data proc-
essing and referencing were per-
formed using NMRPipe (29), and
spectral assignment was performed
with CCPNMR Analysis version
1.0.15 (30).
Competition Experiment—Com-
petition between the FnZ peptide
and the collagen peptide for binding
to 8F19F1 was demonstrated by
fluorescence anisotropy measure-
ments. Samples contained a 50 nM
concentration (determined by ab-
sorbance at 280 nm) of an N-termi-
nally 5-carboxyfluorescein-labeled
1(I) collagen peptide spanning res-
idues 778–799, which has been
shown to bind 8F19F1 with an affin-
ity (Kd) of 4.5 M (17); unlabeled
8F19F1 at concentrations of 10, 20,
or 30 mM; and unlabeled FnZ pep-
tide at increasing concentrations in
a 20 mM Tris-HCl (pH 7.4), 150 mM
NaCl buffer. Samples were excited
at 485 nm with a 515 nm cut-off,
and fluorescence was observed at
538 nm using an M5 fluorometer
(Molecular Devices) at 25 °C. Dif-
ferences in fluorescence anisotropy
(FA) were simultaneously fit for all
8F19F1 concentrations using the formula,
FA  FA,final dFA [P] 0.5aKdBL [P] 0.5a (Eq. 1)
where
a  [P] [CL] KdCL ([P] [CL] KdCL)2 4[P][CL]
(Eq. 2)
whereFA is the fluorescence anisotropymeasured at eachpoint,
FA,final is the fluorescence anisotropy at saturation of competing
ligand (FnZ peptide), [P] is the protein (8F19F1) concentration,
[CL] is the concentration of competing ligand,KdCL is the affin-
ity of the competing ligand, and KdBL is the affinity of bound
ligand (collagen peptide, 4.5 M).
RESULTS
FnZ Binds the 100-kDa N-terminal Region of Fn with High
Affinity—Residues 370–428 of FnZ contains a site with high
sequence homology to NTD-binding FnBRs from S. pyogenes
and S. aureus (2) and to the GBD-binding UR region of SfbI
from S. pyogenes (18, 24) (Fig. 1C). ITC (Fig. 2A and Table 1)
shows that FnZ(370–428) binds a recombinant 100-kDa
N-terminal fragment of Fn containing both the NTD and GBD
(in addition to three F3modules; Fig. 1A) (26) with high affinity
(Kd 0.8 0.1 nM).
FIGURE 1. FnZ and Fn. A, schematic of the 100-kDa N-terminal region of Fn showing F1 (blue), F2 (red), and F3
(pink) modules and showing the location of the NTD and GBD. B, schematic representation of FnZ showing
putative functional domains. S, a signal sequence. Putative FnBRs (R1–R5) are colored dark gray, and the UR
region is shown in orange. M and W, membrane- and wall-spanning regions, respectively. C, sequence align-
ment of putative 8F19F1/GBD binding (UR) and NTD-binding regions (FnBRs) from streptococcal and staphy-
lococcal FnBPs and fromthe1 chainof type I collagen. Residuenumbers aregiven for FnZ, conserved residues
in FnBRs and UR are highlighted in orange, and the location of F1-binding motifs based on published data is
indicated. The FnZpeptide used in this study isunderlined. Hydroxyproline residues in the collagenpeptide are
indicated with an O.
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The UR/spacer of FnZ binds 8F19F1—A sequence alignment
of the UR sequences of FnZ and SfbI with the collagen I 1
peptide (residues 778–799; Fig. 1C) shows that the LAGESGET
motif is conserved between FnZ and SfbI and has some homol-
ogy with the collagen peptide. ITC experiments (Fig. 2 and
Table 1) show that the peptide spanning residues 370–391
from FnZ (Fig. 1C) binds with micromolar affinity to both the
GBD (Kdof 0.54 0.04M; Fig. 2B) and 8F19F1 (Kdof 10.9 0.3
M; Fig. 2C). The relative affinities suggest that the majority of
the FnZpeptide binding site iswithin 8F19F1,with some limited
involvement (through direct binding or through stabilizing
interdomain interfaces) of other residues in GBD.
FnZ Residues 370–391 Bind to 8F1 via an Anti-parallel
-Zipper—The interaction between 8F19F1 and the FnZ pep-
tide was explored using NMR spectroscopy; a series of 1H15N-
HSQC spectra were acquired for uniformly 15N-labeled 8F19F1
with increasing concentrations of peptide (Fig. 3A). The 1H15N-
HSQC spectrum of 8F19F1 when bound to the FnZ peptide was
assigned using three-dimensional 1H15N-HSQC-NOESY and
1H15N-HSQC-TOCSY experiments. A plot of chemical shift
changes between the free and bound forms of 8F19F1 (Fig. 3B)
shows that the most significant differences occur in the
E-strand of 8F1 (Fig. 3C). Chemical shift changes were also
observed in theA-strand of 9F1. In addition, four residues in the
D-E loop of 9F1 could be assigned in the bound form, due to a
sharpening of resonances compared with spectra of the
unbound form of 8F19F1, where their assignment was not pos-
sible. This suggests that in the unbound form, this loop under-
goes conformational exchange, resulting in line broadening
that is reduced upon peptide binding. S. aureus and S. pyogenes
FnBRs and the collagen1(I) peptide bind along the E-strand of
their respective F1 modules in an anti-parallel orientation. Fig.
3,A andB, shows that a shorter peptide (LAGESGET), from the
C terminus of the FnZ 8F19F1-binding peptide, has no affect on
9F1 residues (e.g. Tyr585 and Cys587) that underwent chemical
shift changes upon the addition of the longer peptide. Because
8F1 residues (e.g. Asn542 and Glu536) are affected by binding of
both peptides, it is clear that FnZ also binds 8F19F1 in an anti-
parallel orientation.
The FnZ Peptide Binds Competitively to the Collagen-binding
Site of 8F19F1—The ability of the FnZ peptide to compete with
the collagen peptide for 8F19F1 binding was tested by fluores-
cence anisotropy. Fig. 4 shows that
increasing concentrations of unla-
beled FnZ peptide added to 8F19F1
plus fluorescently labeled collagen
peptide led to a steady decrease in
anisotropy, suggesting dissociation
of the collagen peptide-8F19F1 com-
plex. TheKd of FnZ peptide binding
was determined from this experi-
ment to be 1.9 0.1 M, indicating
tighter binding to 8F19F1 than
observed for the collagen peptide
under similar conditions by fluores-
cence anisotropy (4.5 M) (17).
Together, these results suggest that
residues 370–391 from FnZ bind to
the same region of 8F19F1 as the col-
lagen peptide and through a similar
anti-parallel -zipper mechanism.
DISCUSSION
UR sequences are found in FnBPs
frompathogenic streptococci (2, 18)
and in BBK32, an FnBP from
B. burgdorferi (2, 31). The UR bind-
ing site in SfbI from S. pyogenes had
FIGURE 2. ITC of FnZ binding to Fn domains. The binding isotherms for FnZ(370–428) with the 100-kDa
fragment (A) and the interactionof FnZpeptide 370–391withGBD (B) and 8F19F1 (C) are shown. The top panels
show the heat differences upon injection of peptide, and the lower panels show the integrated heats of injec-
tion, with the best fit to a one-site bindingmodel usingMicroCal Origin. Thermodynamic parameters for these
experiments are summarized in Table 1.
TABLE 1
ITC analysis of interactions of FnZ with Fn domains
Thermodynamic parameters for the interaction of FnZ peptide with 8F19F1 andGBD and of FnZ(370–428) with the 100-kDa Fn fragment. Errors are from the curve fitting.
Fn domain FnZ peptide Fn domain H S Kd n
mM mM kcal/mol cal/mol K1 M
8F19F1 2.97 0.24 29.8 77.2 10.9 0.3 0.86
GBD 0.11 0.01 17.7 30.8 0.54 0.04 0.96
FnZ(370–428) Fn domain H S Kd n
mM mM kcal/mol cal/mol K1 M
100 kDa 0.020 0.001 54.6 134.0 0.0008 0.0001 1.06
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been located to the GBD (18). Here we localized the FnZ UR
binding site within GBD by showing that it binds primarily to
the 8F19F1 module pair.
We were unable to determine the structure of the 8F19F1-
FnZ peptide complex using either NMR spectroscopy or x-ray
crystallography. However, by close comparison of the UR and
collagen peptide sequences with previously identified F1-bind-
ing motifs from S. aureus and S. pyogenes FnBRs and the avail-
able F1 module-peptide structures (Fig. 5), it is possible to
understand the role of conserved
residues in the 8F1-binding motif of
UR. For example, the glycine resi-
due in the GET (UR) or GER (colla-
gen peptide) appears to be con-
served to avoid a steric clash with
Trp553 in the E-strand of 8F1 (Fig.
5A). This is similar to the role of a
conserved glycine residue in S. au-
reus FnBR 3F1-binding motifs (Fig.
5A) (14) because the E-strand of 3F1
contains a tryptophan side chain in
a similar orientation to the 8F1
E-strand tryptophan (Fig. 5). This
E-strand tryptophan residue is not
conserved in 2F1, so here the equiv-
alent peptide residue in the FnBR is
the glutamate of the EDTmotif (Fig.
5B), which forms a salt bridge with
an arginine residue in the C-strand
of the F1 module (Fig. 5A). In the
collagen peptide-8F19F1 structure,
due to the requirement for the gly-
cine, this interaction is shifted two
residues along the peptide and is
formed by the glutamine in GQR
(Fig. 5A) and thus in UR by the glu-
tamate in GES. In 3F1-binding
motifs, there is no equivalent nega-
tively charged or polar residue to interact with the C-strand
arginine, and in isolation, this motif binds 3F1 only very weakly
(13). In 2F1 binding, the aspartate of the EDTmakes polar con-
tacts with an arginine in the loop between the D and E strands.
The sequence of this loop is very similar in 8F1, and the gluta-
mate in the collagen peptide GER makes a similar interaction
(Fig. 5A) as, we suggest, does the glutamate in the GET in UR.
The 3F1-bindingmotif lacks the negatively charged residue that
could interact with the lysine residue in theD-E loop of 3F1.We
predict that the threonine in the GET UR motif interacts with
backbone atoms in the B-strand and D-E loop of the F1module
(as observed for homologous hydroxyl-containing residues in
2F1- and 4F1-binding motifs from S. aureus FnBPA (14)). The
leucine in the LAG (UR) sequence is likely to be involved in
hydrophobic contacts similar to those previously observed for
the leucine in the LPG sequence in the collagen peptide (17).
The role of the glycine in these motifs is less clear and will
require further investigation.
These findings have important implications for the structure
of theGBD. Fig. 6 shows amodel of the 70-kDa region of Fn that
contains both theNTDandGBDand the sequence ofURFnZ-2
(Fig. 1C). The binding sites for F1modules in the FnZ sequence
are indicated, based on our previous work studying homolo-
gous proteins from S. pyogenes (12) (13) and S. aureus (14) and
on the work presented here. What is immediately striking is
that there are only four residues between the most N-terminal
5F1-binding residue and the most C-terminal 8F1-binding res-
idue based on crystal structures of S. aureus FnBPA-1 and
FnBPA-5 peptides in complex with 4F15F1 (14) and on the
FIGURE 3. Identification of the FnZ peptide binding site and binding orientation on 8F19F1 using NMR
spectroscopy.A, overlay of the 1H15NHSQC spectra of free 8F19F1 (black) and of 8F19F1 bound to the FnZ (red)
and LAGESGET (cyan) peptides.Highlighted residues arementioned under “Results.” B, chemical shift perturba-
tion map for 15N-labeled 8F19F1 upon binding to the FnZ (top) and LAGESGET (bottom) peptides. Blue and red
bars indicate absolute chemical shift differences in backbone amide 1H and 15N nuclei, respectively, between
free and peptide-bound 8F19F1. P, proline residues;E, unassigned residues;F, residues previously unassigned
but now identified. The approximate location of previously defined secondary structure elements of the F1
modules are shown above. Peaks that disappear upon peptide binding from their chemical shift in free 8F19F1
but cannot be assigned in the peptide-bound spectrum are indicated by a gray bar of arbitrary size. C, location
of combined chemical shift perturbations (square root of (HN
2 0.2N
2)) on FnZ peptide bindingmapped
onto the structure of 8F19F1 (17) (Protein Data Bank entry 3EJH). Small to large chemical shift changes are
indicated by as follows: cyan	 blue	 yellow	 orange	 red and Trp553 (gray; prepared using PyMOL) (35).
FIGURE 4. Competitive binding of FnZ peptide to 8F19F1 in presence of
collagen peptide, demonstrated by fluorescence anisotropy measure-
ments. Unlabeled FnZ peptide at increasing concentrations was incubated
with unlabeled 8F19F1 at 10 (f), 20 (E), and 30 M () and the collagen
peptide labeled with 5-carboxyfluorescein. Data were fit using Origin soft-
ware. Error bars (S.D.) correspond to instrumental readout error and derive
from triplicate measurements.
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8F19F1-collagen peptide complex (17). Thus, as suggested pre-
viously by the hairpin arrangement of modules in the solution
structure of 6F11F22F2 (32), the GBDmodules appear to have a
non-linear arrangement in the complex. In fact, the FnZ
sequence suggests that the 70-kDa (NTD GBD) fragment of
Fn presents a surface that is largely composed of F1 modules
from both the NTD and GBD and that streptococcal FnBPs
bind across this surface through a highly extended tandem
-zipper, forming a large protein-protein interface.
The UR region in SfbI from S. pyogenes is essential for effi-
cient invasion of bacteria into epithelial cells, resulting in a
10-fold increase in invasion compared with bacteria expressing
constructs that lacked this region and contained only theNTD-
binding FnBRs (18). The precise molecular mechanism of this
effect is unknown. We and others (15, 19) have previously sug-
gested that the role of bacterial FnBRs in adhesion and invasion
might be to disrupt intramolecular Fn-Fn interactions that
maintain the compact conformation that is observed in solu-
tion, thus exposing the integrin binding site in 10F3. The NTD
has been implicated in such intramolecular interactions and
was shown recently to interact with F3 modules (26, 33). It is
less clear whether the GBD modules are involved in intramo-
lecular interactions outside the GBD, but the high affinity and
large intermolecular interface formed by FnBPs that bind both
the NTD and GBDmight be particularly efficient in disrupting
intramolecular Fn-Fn interactions. In addition, the suggestion
that IGD sequences within the GBD of Fn might bind to the
v3 integrin (34) means that UR binding to the GBD could
have a more direct effect on the cell binding activity of Fn.
We showed (Fig. 4) that the FnZ peptide inhibited binding of
a peptide from the1 chain of type I collagen to 8F19F1. Further
workwould be required to determine if FnBPs can inhibit intact
collagen-Fn interactions. Recently, it was shown that collagen I
matrix turnover is regulated by Fn (21), suggesting that the
interaction between polymerized Fn and collagen stabilizes col-
lagen within the extracellular matrix and reduces endocytosis
and degradation of collagen. pUR4, a GBD/NTD-binding
region from SfbI with homology to FnZ (Fig. 1C), inhibits Fn
polymerization and enhances collagen endocytosis and degra-
dation (21). The identification of the UR binding site within
GBD and of the role of conserved residues will aid further stud-
ies of the function of the GBD in both physiological and path-
ological processes involving Fn and how bacterial FnBPs might
modify or exploit these functions during infection.
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